We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Adaptive Designs in Clinical Trials

The latest advances to enhance the precision, efficiency and ethical aspects of your clinical trials

SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials - demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.

Hosting in depth presentations from regulatory agencies, researchers and biostatisticians, the meeting will cover how personalized medicine, platform trials, response-adaptive randomization, signature designs, estimand framework, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America.

The benefits of attending:

At this year’s conference there will once again be an array of networking opportunities:

  • Meet and network with key industry and thought leaders shaping state of the art adaptive design techniques
  • More than 4 hours of networking during the conference days
  • Engage with an array of vendors, with leading solution providers, Mevia and GCE Solutions among those exhibiting last year

Key reasons to attend:

  • See how the regulatory environment for adaptive drug design is shifting across the continent with insights from the MHRA, Amgen, AstraZeneca and Berry Consulting
  • Explore the therapeutic potential of adaptive designs with real-world examples from , GSK Vaccines, Pfizer and Novartis 
  • Listen to how the latest platform trial case studies – such as that of the EPAD project and the MS Society initiative, are impacting pharmaceutical development
  • Delve into the long-standing discussion of Bayesian vs. frequentist designs
  • Discover the latest research in response-adaptive designs: trials for rare diseases and looking forward



LinkedIn: @SMi Pharma

Twitter: #SMi & #smiadaptivedesigns


1 Apr 2019 @ 09:00 am

2 Apr 2019 @ 09:00 am

Duration: 1 days


Holiday Inn Kensington Forum

97 Cromwell Road

United Kingdom

Organised by

SMi Group Ltd.

Recent Publications in Science

Recent Videos in Science

Recent News in Science

Why planet-friendly catering is one of many important solutions to speed up #ClimateChangeAction ➡️… https://t.co/BvtV8u5Fo9

@HorizonMagEU - 25 Jun 2019 18:06

Inspirational ERC grantees from Czechia, Germany & Poland at the European Forum for Science, Research & Innovation… https://t.co/w8WJy6rcBp

@ERC_Research - 25 Jun 2019 14:17

Get ready for your brokerage meetings during #H2020EE #H2020Energy Info Days. We are already preparing the room for… https://t.co/MDvhC2n8Ok

@inea_eu - 25 Jun 2019 13:45

Recent Speakers in Science